Live Breaking News & Updates on Magdalena Licka

Stay updated with breaking news from Magdalena licka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01

/PRNewswire/ Molecure S.A. ("Molecure": WSE: MOC) a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and. ....

United States , Eleanor Perkin , Frazer Hall , Samson Fung , Marcin Szumowski , Andre Hoekema , Magdalena Licka , Sandi Greenwood , Warsaw Stock Exchange , International Institute Of Molecular , Chief Business Officer , David Dible , International Institute , Cell Biology ,

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01

/PRNewswire/ Molecure S.A. ("Molecure": WSE: MOC) a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and. ....

United States , Eleanor Perkin , Frazer Hall , Samson Fung , Marcin Szumowski , Andre Hoekema , Magdalena Licka , Sandi Greenwood , Warsaw Stock Exchange , International Institute Of Molecular , Chief Business Officer , David Dible , International Institute , Cell Biology ,

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Eleanor Perkin , Frazer Hall , Marcin Szumowski , Andre Hoekema , Samson Fung , Kostenloser Wertpapierhandel , Sandi Greenwood , Magdalena Licka , Warsaw Stock Exchange , International Institute Of Molecular , Chief Business Officer , David Dible , International Institute , Cell Biology ,

OncoArendi Therapeutics Reports Continued Strategic and Operational Momentum for 12 Months ended 31 December 2021

- Significant partnership agreement with the world-renowned International Institute of Molecular and Cell Biology in Warsaw (IIMCB) to accelerate the strategic development of OncoArendi's small ....

United States , Eleanor Perkin , Frazer Hall , Marcin Szumowski , Agnieszka Rajczuk Szczepanska , Samson Fung , Rafal Kaminski , Nancy Van Osselaer , Adam Golebiowski , Zbigniew Zaslona , Sandi Greenwood , Magdalena Licka , Warsaw Stock Exchange , International Institute Of Molecular , University Of Michigan , International Institute , Cell Biology , Management Board , First In Human Phase , Chief Medical , Oncoarendi Therapeutics , David Dible ,

OncoArendi Therapeutics Announces a License Option Agreement with University of Michigan

- Option to in-license and develop small molecule leads against a novel target for the treatment of fibrotic diseases - Strengthens pipeline and reinforces OncoArendi's strategic focus ....

Michigan State University , United States , Eleanor Perkin , Frazer Hall , Adam Golebiowski , Bryce Pilz , Nicolas Beuzen , Magdalena Licka , Sandi Greenwood , Office Of The Vice , Warsaw Stock Exchange , International Institute Of Molecular , University Of Michigan , Innovation Partnership , Business Development , Vp Research Chemistry , Innovation Partnerships University Of Michigan , Innovation Partnerships , Executive Director , Strategic Alliances , Um Innovation , International Institute , Cell Biology , Oncoarendi Therapeutics , Innovation Partnerships University , Vice President ,